The Lancet: novel coronavirus infection is more harmful than steroids in treating new coronavirus infection.

February 11, 2020 / BIOON / -- recently, a report was published in the lancet Novel coronavirus infection may be avoided by steroids, according to the study by scientists from University of Edinburgh Based on previous experience and evidence from researchers in treating similar infections such as SARS, researchers believe that steroids have almost no benefit to patients, and they do more harm than good 。
Source: novel coronavirus CC0 Public Domain clinicians should still treat asthma and other inflammatory diseases Steroids are usually used by doctors to reduce inflammation Inflammation is often present in the lungs of new coronavirus patients During SARS and MERS outbreaks, the lungs of patients also show inflammatory manifestations caused by coronavirus infection However, steroids can damage the immune system's ability to resist viruses and other infections In general, the use of steroids can cause serious damage to the patient's body A retrospective study of critically ill patients with mers found that nearly half of the patients who received steroids needed additional therapy, such as assisted respiration therapy, drugs to increase blood pressure and dialysis, while those who took steroids took longer to clear the virus Other studies have shown that steroids can cause damage to patients during the SARS outbreak, while the virus still exists in those who take the drug three weeks after infection The novel coronavirus outbreak is a difficult choice for clinicians during the outbreak of coronavirus After careful analysis of the existing evidence, I do not recommend steroids to treat lung damage caused by new coronavirus infection It is probably suggested that steroids should be used as a clinical trial, J Kenneth Baillie said Part of it is to understand whether it can help or harm the patient Original source: Clark D Russell, Jonathan e Millar, J Kenneth Baillie Clinical evidence does not support corticosteroid treatment for 2019 ncov lung junior The lancet, 2020 doi: 10.1016/s0140-6736 (20) 30317-2